1. What are the strengths and weaknesses of the US transplant system?
2. Identify the major stakeholders in the US transplant system and their interests in changing the system or maintaining the status quo.
3. What are the key challenges that Tayur is likely to encounter in launching and operating OrganJet and Guardian Wings?
4. If Tayur wants to help radically transform the US transplant system, what should he do?

Using the Harvard business study to answer